KeithAlanFriedenbergMDMBA

Gastroenterology • Mentor, OH

Great Lakes Gastroenterology

Join to view full profile

Dr. Friedenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Friedenberg's full profile

Already have an account?

Office
8877 Mentor Ave
Mentor, OH 44060
Phone+1 440-205-1225

Fax+1 440-205-1275

Education & Training

Indiana University Kelley School of Business MBA, 2018 - 2020
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gastroenterology, 1991 - 1994
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1988 - 1991
David Geffen School of Medicine at UCLAClass of 1988

Certifications & Licensure

CA State Medical License 1989 - Present
OR State Medical License 1993 - Present
OH State Medical License 1994 - 2027
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Top MD Consumers Checkbook

Clinical Trials

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) Start of enrollment: 2016 May 19
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

17 citations
Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation
Satish S.C. Rao, Anthony Lembo, William D. Chey, Keith Friedenberg, Eamonn Martin Quigley
Neurogastroenterology and Motility. 2020-05-25
135 citations
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
William J. Sandborn, Joshua R. Korzenik, Bret A. Lashner, Jonathan A. Leighton, Uma Mahadevan
Gastroenterology. 2010-04-01
29 citations
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s ...
Stefan Schreiber, Corey A. Siegel, Keith Friedenberg, Ziad Younes, Ursula Seidler
Journal of Crohn's & Colitis. 2018-08-29

Press Mentions

IWBI Welcomes Additional Leaders to the WELL Health-Safety Advisory for Sports and Entertainment VenuesJune 10th, 2020
L’International WELL Building Institute Lance La Notation WELL Sécurité Sanitaire Pour L’exploitation Et La Gestion D’installations De Sites Sportifs Et De DivertissementMay 16th, 2020